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                                             ABSTRACT 
 
The present investigation has been undertaken to study the wound healing 
properties of aqueous extract of Zanthoxylum rhetsa. The plant Zanthoxylum 
rhetsa has a long history in herbal medicine in many countries. Experiments 
were conducted following standard procedures. The extracts were evaluated 
for their in vitro antioxidant, antimicrobial and total phenol and flavonoid 
content. The  AQZR ointment were administered topically, for evaluating the 
wound healing potential in excision wound model for twenty one days. 
Povidone iodine ointment was used as a standard for wound healing in 
excision wound model. Extract treated group showed in vitro antioxidant, 
antimicrobial properties compared with standard and control. AQZR exhibited 
similar in vivo wound healing activity that of the standard but with lesser 
magnitude. The result may be attributed to the phytoconstituents such as 
flavonoids and phenolics present in it which may be due to their individual or 
cumulative effect that enhanced wound healing and provided scientific 
evidence to the ethnomedicinal futures of Zanthoxylum rhetsa. These findings 
could justify the inclusion of this plant in the management of wound healing. 
 
 
 
Keywords: AQZR, Wound healing potential, Phytoconstituents.  
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1. INTRODUCTION 
  
1.1 HERBAL MEDICINES [1][2][3][4] 
  Herbal medicines which formed the basis of health care throughout the world 
since the earliest days of mankind are still widely used, and have considerable 
importance in international trade. Recognition of their clinical, pharmaceutical and 
economic value is still growing, although this varies broadly between countries. 
Medicinal plants are important for pharmacological research and drug 
development, not only when plant constituents are used directly as remedial agents, 
but also as starting materials for the synthesis of drugs or as models for 
pharmacologically active compounds. Regulation of development and exportation is 
therefore essential, together with international cooperation and coordination for their 
conservation so as to ensure their availability for the future. 
 
The United Nations Convention on Biological Diversity states that the 
conservation and sustainable use of biological diversity is of critical importance for 
meeting the food, health and other needs of the growing world population, for which 
purpose access to and sharing of both genetic resources and technologies are 
essential.
 
Legislative controls in respect of medicinal plants have not evolved around a 
structured control model. There are different ways in which countries define 
medicinal plants or herbs or products derived from them, and countries have adopted 
various approaches to licensing, dispensing, manufacturing and trading to ensure their 
safety, quality and efficacy.  
Despite the use of herbal medicines over many centuries, only a relatively 
small number of plant species has been studied for possible medical applications. 
Safety and efficacy data are available for an even smaller number of plants, their 
extracts and active ingredients and preparations containing them. 
India is a birth place of indigenous medicine such as Siddha, Ayurveda and Unani 
where many herbs have been used for treatment of human ailments. About 65% of 
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total global population remains dependent on traditional medicines for their primary 
healthcare. Herbs are occupying a comeback and an Herbal Renaissance is blooming 
across the world. They have been evidently prized for their medicinal, flavoring and 
aromatic qualities for centuries, yet for a while they were over shadow by synthetic 
products of modern civilization. Folk medicine is generally defined as traditional 
medicine that is practiced by non-professional healers or embodied in local custom or 
lore, generally involving the uses of natural and especially herbal remedies. The 
World Health Organization (WHO) defines traditional medicine as “the health 
practices, approaches, knowledge and believes incorporating plant, animal and 
mineral-based medicines, spiritual therapies, manual techniques and exercise, applied 
singularly or in combination to treat, diagnose and prevent illness or maintain well-
being.” Treatments are specific to a particular ailment and may include the power of 
rare, dancing, sweet baths, massage, medicinal herbs, hot and cold foods or other 
means not practiced in modern medicine. 
Once having realized their sources and adverse effects, people are going to 
nature with hopes of safety and security. The rich treasure of herbal drugs is forming a 
boon for our society. Plant derived compounds, apart from their nutritive values, could 
serve as important therapeutic weapons to fight various human and animal diseases, 
thereby making them indispensable in traditional medicine for treating a number of 
diseases. Plant drugs, popularly known as herbal medicines have since been 
unabatedly used to that various diseases. The major challenge is to protect traditional 
knowledge and will prove to be a beneficial asset to our human surrounding. For all 
the ailments herbal formulations are proved to be effective without any side effects 
commonly seen with allopathic drugs.
 
1.2 INFLAMMATION [5][6] 
Inflammation (Latin, inflammatio) is part of the complex biological response of 
body tissues to harmful stimuli, such as pathogens, damaged cells, or irritants. 
Inflammation is a protective response that involves immune cells, blood vessels, and 
molecular mediators. The purpose of inflammation is to eliminate the initial cause of cell 
injury, clear out necrotic cells and tissues damaged from the original insult and the 
inflammatory process, and to initiate tissue repair. 
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 The classical signs of acute inflammation are pain, heat, redness, swelling, and 
loss of function. Inflammation is a generic response, and therefore it is considered as a 
mechanism of innate immunity, as compared to adaptive immunity, which is specific for 
each pathogen. 
 Inflammation is tightly regulated by the body. Too little inflammation could lead 
to progressive tissue destruction by the harmful stimulus (e.g. bacteria) and compromise 
the survival of the organism. In contrast, chronic inflammation may lead to a host of 
diseases, such hay fever, periodontitis, atherosclerosis, rheumatoid arthritis, and even 
cancer (e.g., gallbladder carcinoma). Inflammation is therefore normally closely 
regulated by the body. 
 Inflammation can be classified as either acute or chronic. 
  Acute inflammation is the initial response of the body to harmful stimuli and is 
achieved by the increased movement of plasma and leukocytes (especially granulocytes) 
from the blood into the injured tissues.  Prolonged inflammation, known as chronic 
inflammation, leads to a progressive shift in the type of cells present at the site of 
inflammation and is characterized by simultaneous destruction and healing of the tissue 
from the inflammatory process. 
 Inflammation is not a synonym for infection. Infection describes the interaction 
between the action of microbial invasion and the reaction of the body's inflammatory 
defensive response.  
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Table:1 Comparison Between Acute and Chronic Inflammation 
[7]
 
Factors  Acute Inflammation Chronic Inflammation 
Causative agent 
Bacterial pathogens, injured 
tissues 
Persistent acute 
inflammation due to non-
degradable pathogens, viral 
infection, persistent foreign 
bodies, or autoimmune 
reactions. 
Major cells involved 
Neutrophils (primarily), 
basophils (inflammatory 
response), and eosinophil’s 
(response to helminth 
worms and parasites),  
Mononuclear cells 
(monocytes, macrophages, 
lymphocytes, plasma cells), 
fibroblasts 
Primary mediators 
Vasoactive amines,  
Eicosanoids. 
IFN-γ and other cytokines, 
growth factors, reactive 
oxygen species, hydrolytic 
enzymes 
Onset Immediate Delayed 
Duration Few days 
Up to many months, or 
years 
Outcomes 
Resolution, 
chronic inflammation 
Tissue destruction, fibrosis, 
necrosis 
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Acute inflammation is a short-term process, usually appearing within a few minutes or 
hours and begins to cease upon the removal of the injurious stimulus. It is characterized 
by five cardinal signs: An acronym that may be used to remember the key symptoms is 
"PRISH" for Pain, Redness, Immobility (loss of function), Swelling and Heat. 
 The traditional names for signs of inflammation come from Latin:
[8][9][10]
 
 Dolor (pain) 
 Calor (heat) 
 Rubor (redness) 
 Tumor (swelling) 
 Functiolaesa (loss of function) 
 The first four (classical signs) were described by Celsus (ca. 30 BC–38 
AD), while loss of function was added later by Galeneven though the attribution is 
disputed and the origination of the fifth sign has also been ascribed to Thomas 
Sydenham and Virchow. 
Redness and heat are due to increased blood flow at body core temperature to the 
inflamed site; swelling is caused by accumulation of fluid; pain is due to the release of 
chemicals such as bradykinin and histamine that stimulate nerve endings. Loss of 
function has multiple causes. 
 Acute inflammation of the lung (pneumonia) does not cause pain unless the 
inflammation involves the parietal pleura, which does have pain. 
Inflammatory disorders 
[11]
 
 Inflammatory abnormalities are a large group of disorders that underlie a vast 
variety of human diseases. 
 Examples of disorders associated with inflammation include: 
 Acne vulgaris 
 Asthma 
   Autoimmune diseases 
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 Auto inflammatory diseases 
 Celiac disease 
 Chronic prostatitis 
 Glomerulonephritis 
 Hypersensitivities 
 Inflammatory bowel diseases 
 Reperfusion injury 
 Rheumatoid arthritis 
 Sarcoidosis 
 Transplant rejection 
 Vasculitis 
 Interstitial cystitis 
 
1.3 WOUND HEALING ACTIVITY [12] 
Wounds are inescapable events in life. Wounds may arise due to physical, chemical or 
microbial agents. Wound healing involves a complex series of interactions between 
different cell types, cytokine mediators, and the extracellular matrix. The phases of 
normal wound healing include hemostasis, inflammation, proliferation and remodeling. 
Each phase of wound healing is distinct, although the wound healing process is 
continuous, with each phase overlapping the next. Because successful wound healing 
requires adequate blood and nutrients to be supplied to the site of damaged tissue. 
CLASSIFICATION OF WOUNDS 
Wounds are classified as open wounds and closed wounds on the basis of underlying 
cause of wound creation and as acute and chronic wounds on the basis of physiology of 
wound healing  
(a)  Open Wound: 
[13]
 
Though the open wound blood escapes the body and bleeding is clearly visible. 
Open wound is further classified as: 
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 Incised Wounds: 
              It is an injury with no tissue loss and minimal tissue damage. It is caused 
by a sharp object such as knife. Bleeding in such cases can be profuse, so 
immediate action should be taken. 
 Abrasions or superficial Wounds: 
             It is caused by sliding fall on to a rough surface. During abrasion the 
topmost layer of the skin i.e. epidermis is scraped off that exposes nerve ending 
resulting in a painful injury. Blood loss similar to a burn can result from serious 
abrasions. 
 Laceration wound or tears Wounds: 
            This is a nonsurgical injury in conjunction with some type of trauma, 
resulting in tissue injury and damage. 
 Puncture Wounds: 
              They are caused by some object puncturing the skin, such as needle or 
nail. Chances of injection in them are common because dirt can enter into the 
depth of wound. 
 Gunshot Wounds: 
               They are caused by a bullet or similar driving into or through the body. 
 Penetration Wounds: 
                Penetration wounds are caused by an object such as knife entering and 
coming out from the skin. 
(b) Closed Wounds: 
          In closed wounds blood escapes the circulating system but remain in the body. It 
includes contusion or bruises, heamatomas or blood tumor, crush injury etc. 
 Contusions or bruises: 
                Bruises are caused by a blunt force trauma that damage tissue under the 
skin. 
 Hematomas or blood tumor: 
                They are caused by damage to a blood vessel that consequently causes 
blood to collect under the skin. 
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 Crush injury: 
                Crush injury is caused when great or extreme amount of force is 
applied on the skin over long period of time. 
 Acute Wounds: 
An acute wound is a tissue injury that normally proceeds through an orderly and 
timely reparative process that results in sustained restoration of anatomic and 
functional integrity. Acute wounds are usually caused by cuts or surgical 
incisions and complete the wound healing process within the expected time 
frame. 
 Chronic wounds: 
                C hronic wounds are wounds that have failed to progress through the 
normal stages of healing and therefore enter a state of pathologic inflammation 
chronic wounds either require a prolonged time to or recur frequently. Local 
infection, hypoxia, trauma, foreign bodies and systemic problems such as 
diabetes mellitus, malnutrition, immunodeficiency or medications are the most 
frequent causes of chronic wound. 
FACTORS AFFECTING WOUND HEALING 
[14]
 
 Improper diet. 
 Infection at the wound site. 
 Insufficient oxygen supply and tissue perfusion to the wound area. 
 Drugs. 
 Elderly age. 
 Diabetes and other diseases conditions. 
Wound healing is normal biological process in the human body. Many factors can 
adversely affect this process and lead to improper and impaired wound healing. 
Improper Diet: 
Wound healing is an anabolic process that requires both energy and nutritive substrates. 
It is reported that serum albumin level of 3.5mg/dl or more is necessary for proper 
wound healing. Protein is essential for collagen synthesis on wound site. A state 
malnutrition may provide an inadequate amount of protein and this can decreased the 
rate of collagen synthesis, wound tensile strength or increased chance of infection. 
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Infection at the wound site: 
Wound infection is probably the most common reason of impaired wound healing by 
Streptococcus aereus, Streptococcus pyrogens, Escherichia coli, and Pseudomonas 
aeruginosa. 
Insufficient Oxygen Supply and Tissue Perfusion to the Wound area: 
Adequate blood supply and tissue perfusion is extremely important for wound healing. 
Excessive pain, cold and anxiety can cause local vasoconstriction and increased healing 
time. Smoking and use of tobacco decreased tissue perfusion and oxygen tension in 
wound. 
Drugs: 
Many drugs are known to impair wound healing. Chemotherapeutic drugs are used in 
cancer are the largest group well known to delay wound repair. Systemic glucocorticoids 
interfere normal healing process by reducing collagen synthesis and fibroblast 
proliferation. 
Elderly Age: 
Elderly age is found to be associated with delay wound healing. It is reported that the 
fibroblast growth and activity diminishes and collagen production, wound contraction is 
slow in older individuals 
Diabetes and Other Diseases: 
Diabetic patients are more susceptible to wound healing. In the studies wound infection 
rate was found 11% higher in diabetic patients than in general patient’s populations. 
Acute and chronic liver diseases also associated with delay wound healing. Patients with 
altered immune functions have an increased susceptibility to wound infection. 
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PHASES INVOLVED IN WOUND HEALING: 
 The Inflammatory phase 
 Fibroblastic phase 
 Epithelialization phase 
 Proliferative phase 
 Contraction phase  
 Remodeling phase 
THE INFLAMMATORY PHASE: 
[15]
 
The inflammatory phase starts immediately after the injury that usually last between 24 
and 48hrs and may persist for up to 2 weeks in some cases the inflammatory phase 
launches the haemostatic mechanisms to immediately stop blood loss from the wound 
site. Clinically recognizable cardinal sign of inflammation, rubor, calor, tumor, dolor and 
functionless appear as the consequence. This phase is characterized by vasoconstriction 
and platelet aggregation to induce blood clotting and subsequently vasodilatation and 
phagocytosis to produce inflammation at the wound site. 
FIBROBLASTIC PHASE: 
[16]
 
The second phase of wound healing is the fibroblastic phase that lasts upto 2 days to 3 
weeks after the inflammatory phase. This phase comprises of three steps viz. granulation, 
contraction and epithelialization in the granulation step fibroblasts form a bed of 
collagen and new capillaries are produced. Fibroblast produces a variety of substances 
essential for wound repair including glycosaminoglycans and collagen. Under the step of 
contraction wound edges pull together to reduces the defects in the third step epithelial 
tissues are formed over the wound site. 
EPETHELIALIZATION PHASE: 
[17]
 
Epithelial cell migration is one of the vital processes of wound healing. The stem cells of 
epithelium must detach from the edges of the wound and migrate into wound. Normally 
dermal basal cells adhere to each other and to the underline basal layer of the dermis. 
Following mobilization, epithelial cells begin to enlarge and migrate down and across the 
wound. Transected hair follicles also contribute to the number of migrating epithelial 
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cells.  Epithelial cell migrating across wound usually along the basal lamina or fibrin 
deposits, this phenomenon is called contact guidance and is an important factor in 
epithelial migration. Epithelial migration is followed by increased mitosis of epithelium. 
Recent evidence suggests that a water soluble heat labile substance called chalcone 
which is secreted at the wound site is responsible for regulation for mitosis. 
PROLIFERATIVE PHASE: 
[18]
 
Proliferative phase (2 days to 3 weeks) includes: 
 Granulation stage: Fibroblasts lay bed of collagen fills defect and 
produces new capillaries. 
 Contraction stage: Wound edges pull together to reduce defect. 
 Epithelialization stage: Crosses moist surface cell travel about 3cm from 
point of origin in all directions. 
CONTRACTION PHASE: 
[19]
 
Wound contraction is caused by the action of differentiated fibroblasts (myofibroblasts) 
in the granulation tissue, which contain filaments of smooth muscle action. Contraction 
of these fibroblasts makes the wound margins move toward the center of the wound. 
Wound contraction started sooner in ponies than in horses and it was significantly more 
pronounced in ponies. Additionally, it was significantly more pronounced in body 
wounds compared with the limb wounds. As a result, intention wound healing was 
significantly faster in ponies than in horses, and significantly faster in body wounds than 
in metatarsal wounds. Histology showed that myofibroblasts were more organized in the 
wounds of the ponies: the myofibroblasts in the newly formed granulation tissue were 
transformed into a regularly organized pattern within 2 weeks, in which the cell were 
orientated perpendicular to the vessels and parallel to the wound surface. This appears to 
be a more favorable condition for wound contraction to occur. In the horses, 
myofibroblast organization took much longer. No differences were found in the number 
of fibroblasts, the amount of smooth muscle action and collagen. Further research was 
performed to investigate whether the differences in wound contraction between horses 
and ponies were caused by differences in the inherent contraction capacity of fibroblasts 
or the local environment of the fibroblasts. It was found that no differences existed in the 
inherent contraction capacity of fibroblasts from ponies and horses in vitro. However the 
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level of transforming growth factor, the most important instigator of wound contraction, 
was significantly higher in the granulation tissue of pony wounds compared with horse 
wounds. 
REMODELING PHASE: 
[20]
 
This phase last for 3 weeks to 2 years. New collagen is formed in this phase. Tissue 
tensile strength is increased due to intermolecular cross-linking of collagen via vitamin-C 
dependent hydroxylation. The scar flattens and scar tissues become 80% as a strong as 
the original. 
                  The wound healing activities of plants have since been explored in folklore. 
Many ayurvedic herbal plants have a very important role in the process of wound 
healing. Plants are more potent healers because they promote the repair mechanisms in 
the natural way. Extensive research has been carried out in the area of wound healing 
management through medicinal plants. Herbal medicines in the wound management 
involve disinfection, debridement and providing a moist environment to encourage the 
establishment of the suitable environment for natural healing process. 
ACTIVITIES LEADING TO WOUND HEALING 
(a) Anti-inflammatory Activity: 
The acute inflammatory response during the early stages of injury generates factors that 
are essential for tissue growth and repair. When prolonged, however, chronic 
inflammation can to be detrimental, preventing wound remodeling and matrix synthesis, 
leading to delay in wound closure and an increase in wound pain. Thus, it is possible that 
an anti-inflammatory effect could facilitate wound healing and improve patient comfort, 
although traditional texts and animal studies indicate that extracts exert an anti-
inflammatory effect. 
(b) Antioxidant Effect: 
The production of free radicals at or around the wound may contribute to delay in wound 
healing through the destruction of lipids, proteins, collagen, proteoglycan and hyaluronic 
acid. Agents that demonstrate a significant antioxidant activity may, therefore, preserve 
viable tissue and facilitate wound healing. 
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(c) Antimicrobial Activity: 
Wound healing can also be delayed when microoganisms are present in large enough 
numbers. Therefore, reducing the bacterial load of a wound may be necessary to 
facilitate wound healing as well as to reduce local inflammation and tissue destruction. 
An ideal agent for the prevention and control of wound infection would therefore be one 
that directly destroys the pathogens while also stimulate immune activity. 
(d) Analgesic Activity: 
The open wounds can generate pain and subsequent disability, it is important that the 
dressing applied does not increase pain, and if possible, it should lessen the pain. 
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2. PLAN OF WORK 
 
1. Review of Literature. 
2. Selection Collection and Authentication of Plant Material. 
3. Extraction of plant material stem with Water. 
4. Preliminary Phytochemical analysis  
5. Quantification of total Phenol and Flavonoid content. 
6. Invitro antioxidant study  
 DPPH radical scavenging assay. 
 
 ABTS radical cation assay. 
 
 Nitric oxide scavenging assay. 
7. In vitro antimicrobial study. 
 Antibacterial. 
 
 Antifungal. 
8. Pharmacological study. 
9. Histopathological study. 
10. Statistical analysis. 
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3. LITERATURE REVIEW 
1. M.T.Rahman, et al., Antinociceptive and Antidiarrheal activity. The methanolic 
extract of the Zanthoxylum rhesta (Roxb.) DC. Stem bark. Significantly reduced the 
abdominal contraction induced by acetic acid and the diarrheal episodes induced by 
castor oil in mice. [21] 
2. Md.Khrul Islam, et al., Anti-nociceptive and Antioxidant activity. Different parts of 
the medicinal plant Zanthoxyllum budrunga wall seeds (ZBSE) to evaluate its 
antinociceptive and antioxidant potential. [22] 
3. T.G.Nagaraja et al., In-vitro Antibacterial properties. Invitro screening of 
antibacterial properties of Z.rhesta (Roxb.) DC. of bark & stem showed antibacterial 
properties. [23] 
4. T.G.Nagaraja et al., In-vitro evaluation of Anti-fungal properties. Invitro screening 
of anti-fungal properties of root, stem & bark of Zanthoxylum rhesta (Roxb.) DC. 
possess good fungicidal properties against alternaria alternate, aspergillus niger, 
fusarrium oxysporum, cladosporum sp., macrophoma phaseolina and thrichoderma 
viridi. [24] 
5. Aparna Saraf et al., Chemical profile studied. To establish the chemical fingerprint 
of various secondary metabolites of Zanthoxylum rhesta (Roxb.) DC. A medicinally 
important plant. HPTLC profiles of various individual secondary metabolites were 
done and profiles developed for authentication. This study was useful in 
differentiating the species from the adulterant and also act as biomarker for this plant 
in the pharmaceutical industry. [25] 
6. Anwarul Islam abu sayeed et al., Brain shrimp lethality bioassay. The cytotoxic 
activity of free terpenes isolated from the bark of Zanthoxylum budrunga wall used 
in folk medicine in Bangladesh, was evaluated by brine shrimp lethality bioassay. [26] 
7. Suresh lalitharani et al., G.C-MS analysis. The investigation deals with GC-MS 
analysis of ethanolic extract of the spine of the Zanthoxylum rhesta (Roxb.) DC. 
plant fifteen compound were identified. [27] 
8. S.Lalitharani,et al., Pharmacognostic studies. Investigation deals with 
pharmacognostic studies, phytochemical studies and fluorescence analysis. The 
present investigation deals with the pharmacognostic studies of the spine of the said 
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plant. Pharmacognostic studies include microscopic, physicochemical constants, 
fluorescence analysis and preliminary phytochemical evaluations. [28] 
9. Temin payum et al., Antioxidant potencial .The methanolic extract of shoot were 
evaluated for total phenolic content (folin-ciocalteu’s method), total flavonoids 
content (colorimetric method) and antioxidant potential (DPPH and ABTS). [29] 
10. R.Rajashri Naik, et al., GC-MS Analysis and biological evaluation of Essential oil 
of Zanthoxylum rhetsa(Roxb.) DC pericarp. The present study reports the chemical 
composition, antioxidant, antimicrobial, antidiarrheal as well as the spasmolytic 
activity of Zanthoxylum rhetsa(Roxb)DC essential oil, fractionated oil and its 
principal constituent (Terpinen-4-ol) The constituents of essential oil were 
characterized by GC-FID and GC-MS. The pharmacological and biological activities 
of oil, its fraction and principal constituent were carried out in-vivo and in-vitro. The 
study suggests that the oil and its main active constituent (Terpinen-4-ol) of the 
studied plant would have high potential in the treatment of stress and gastro intestinal 
diseases. [30] 
11. Rajashrinaik, et al., GC-FID Analysis of fatty acids and biological Activity of 
Zanthoxylum rhetsa ( Roxb.) DC seed oil. The fatty acid content and composition of 
fixed oil from Zanthoxylum rhetsa seeds was determined. The seeds were found to 
contain about -19.5% of crude foxed oil on dry weight basis. Fatty acids were 
converted in to methyl esters and analyzed GC-FID. Ten fatty acids were identified 
using GC-FID. The major monosaturated and saturated fatty acids were oleic acids 
and palmitic acids respectively, whereas the alpha linolenic acid and linolenic acid 
were poly unsaturated fatty acid. Fixed oil exhibited significant free radical 
scavenging activity which was measured using DPPH, and is also known to inhibit 
the gastrointestinal motility significantly. [31] 
12. A Ramesha Rao, et al., Chemoprotective influence of Zanthoxylum sps. On hepatic 
carcinogen metabolizing and antioxidant enzymes and skin papillomagenesis in 
murine model. In the present study, the putative of pericarp of dried fruit 
Zanthoxylum (Rutaceae Family), a common spice additive in Indians west coast 
cuisines, in protecting against carcinogenesis has been reported. Result showed a 
significant reduction in tumor incidence from 68% to 36% (p<0.05); as well as, a 
reduction in tumor burden from effective mouse from 3.87 to 0.72 (p<0.01). 
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Cumulative, the findings strongly suggest cancer chemo preventive potential of 
Zanthoxylum sps. [32] 
13. S.K.Nazrul islam et al.,Constituents and cytotoxicity of Zanthoxylum rhetsa stem 
bark. Xanthyletin and sesamin have been isolated from petroleum ether extract of the 
stem bark of Zanthoxylum rhetsa. The petroleum ether extract showed cytotoxicity 
on brine shrimp nauplii. [33] 
14. Vijitr Udeye et al., Characteriaztion of the Essential oil and Fatty oil from 
Makhwaen fruit (Zanthoxylum rhetsa (Roxb.) DC). [34] 
15. Khozirah shaari et al., Bioactive constituents of Zanthoxylum rhetsa. Bark and its 
Cytotoxicity Potential against B16-F10 Melanoma cancer and Normal Human 
Dermal Fibroblast (HDF) Cell lines. This plant has been predominantly used by 
Indian tribes for the treatment of many infirmities like diabetes, inflammation, 
rheumatism, toothache and diarrhea. The presence of bioactive lignans and alkaloids 
were suggested to be responsible for the cytotoxicity property of Z.rhetsa bark 
against B16-F10 cells. [35] 
16. V.S. Rana et al.,Volatile constituents of the seed coat of Zanthoxylum rhetsa( Roxb.) 
DC. The chemical composition of the volatile oil of  Zanthoxylum rhetsa seed coat 
was analyzed by GC and GC/MS. Thirty four compounds, accounting for 87.4% of 
the oil were identified. The major compounds were terpinen-4-ol(32.1%), alpha-
terpineol(8.2%), sabinene (8.1%), and 2-undecanone(7.1%). [36] 
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4. PLANT PROFILE [37][38][39] 
 
 
                                            Figure:1 Zanthoxylum rhetsa (Roxb.) DC. 
INTRODUCTION: 
General Information of Zanthoxylum rhetsa(Roxb.) DC. 
A genus of herbs belongs to the family Rutaceae well distributed in India, 
Bangladesh, Bhutan, China etc. 
 
Fifteen species are found naturalized in India and Bangladesh. 
1. Zanthoxylum rhetsa(Roxb.)DC. 
2. Zanthoxylum nitidum 
3. Zanthoxylum chalybeum 
4. Zanthoxylum americanum. 
5. Zanthoxylum oxyphyllum 
6. Zanthoxylum armatum 
7. Zanthoxylum piperitum 
8. Zanthoxylum simulans 
9. Zanthoxylum bungeanum max 
10. Zanthoxylum sehinifolium 
11. Zanthoxylum nitidumRoxb 
12. Zanthoxylum armatum DC(or) alatumRoxb 
13. Zanthoxylum limonella 
14. Zanthoxylum avicennae (Lamk) DC 
15. Zanthoxylum acanthopodium DC 
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LATIN BINOMIAL & VERNACULAR NAMES: 
            Source   : Zanthoxylum rhetsa (Roxb.) DC. 
 Synonym  : Budrunga 
 Family   : Rutaceae 
VERNACULAR NAMES:  
General Name  -  Kasabang(llk),kayatena(tag) 
English Name  -  Indian prickly ash-tree. 
Botanical Name -  Zanthoxylumrhetsa (Roxb.) DC. 
Tamil Name   -  Veerasangi 
Sanskrit  - Lakhuvalka(la), Asvaghra. 
 Malayalam  - Mulilam, Mulliyllam, Karimurikka. 
Kannada  - Aramadala,Arampala,Jammina 
Hindi Name  -  Badrang. 
 
SCIENTIFIC CLASSIFICATION: 
Kingdom  - Plantae 
Phylum  -  Tracheophyta 
Division  - Eukaryota 
 Class   -  Spematopsida 
Order   - Sapindales 
Suborder  -  Rutineae 
 (Unranked)  - Angiosperms, Eudicots, Rosids 
 Family   -  Rutaceae 
 Subfamily  - Rutoideae 
Tribe   - Zanthoxyleae 
 Genus   - Zanthoxylum 
Species  - Zanthoxylum rhetsa 
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                                       5. METHODOLOGY 
 
5.1. PLANT COLLECTION AND AUTHENTICATION 
The stem part of the plant Zanthoxylum rhetsa (Roxb) DC was collected from 
Palakkad District of Kerala and authenticated from the Plant Anatomy Research Center, 
Tambaram, Chennai, Tamil Nadu. The authentication certificate number is 
PARC/2016/3324. Soon after collection, the stems were cleaned and shade dried. After 
drying, these stems were crushed to a coarse powder, stored in air tight plastic container 
for further use. 
5.2. EXTRACTION OF THE PLANT MATERIAL
 [40] 
  The coarsely powdered stem (200gm) were taken in a round bottom flask and 
with water for 48hours at room temperature. After extraction the extracts were 
evaporated or concentrated by using rotary evaporator and dried at room temperature. 
The obtained crude extracts were weighed and stored at 4
0
C for the further analysis. 
5.3. QUALITATIVE PHYTOCHEMICAL ANALYSIS OF AQZR  
[41][42][43][44] 
5.3.1. Preparation of test sample 
A small quantity of the extract was dissolved in 5ml of distilled water and 
filtered. The filtrate was tested to detect the presence of various phytochemical 
constituents in the sample. 
5.3.2. TEST FOR CARBOHYDRATES 
 Molisch’s test 
Few drops of Molisch’s reagent was added to 2-3ml of filtrate, followed by addition 
of concentrated sulphuric acid along the sides of the test tube. Formation of violet colour 
ring at the junction of two liquids indicates the presence of carbohydrates. 
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 Fehling’s test 
1ml Fehling’s-A (copper sulphate in distilled water) was added to 1ml of Fehling’s-B 
(potassium tartarate and sodium hydroxide in distilled water) solution, boiled for one 
minute. To this added 1ml of filtrate and heated gently. Formation of brick red 
precipitate indicates the presence of reducing sugars. 
 Benedict’s test 
Few ml of filtrate was mixed with equal volume of Benedict’s reagent (alkaline 
solution containing cupric citrate complex) and heated in boiling water bath for 5min. 
Formation of reddish brown precipitate infers the presence of reducing sugars. 
 
5.3.3. TEST FOR ALKALOIDS 
Small amount of extract mixed with few ml of dilute hydrochloric acid. Shaken 
well and filtered. Following tests were performed with the obtained filtrate. 
 Dragendorff’s test 
A few drops of Dragendorff’s reagent (potassium bismuth iodide solution) was 
added to 2-3ml of filtrate. Orange red precipitate indicates the presence of alkaloids. 
 Mayer’s test 
 A few drops of Mayer’s reagent (potassium mercuric iodide solution) was added 
to 2-3ml of filtrate. Cream (dull white) precipitate was formed. 
 Wagner’s test 
 A few drops of Wagner’s reagent (solution of iodine in potassium iodide) was 
added to 2-3ml of filtrate. Reddish brown precipitate was obtained. 
 Hager’s test 
A few drops of Hager’s reagent (Picric acid) was added to 2-3ml of filtrate. 
Yellow precipitate was obtained. 
 
5.3.4. TEST FOR TRITERPENOID 
 
 Libermann-Burchard test 
A small quantity of extract was treated with few drops of acetic anhydride, followed by a 
few drops of concentrated sulphuric acid. A brown ring was formed at the junction of 
two layers and the upper layer turns green colour, infers the presence of phytosterols and 
formation of deep red colour indicates the presence of triterpenoids. 
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 Salkowski test 
A small quantity of the extract was treated with chloroform and few drops of 
concentrated sulphuric acid and allowed to stand for few minutes. Yellow colour at the 
lower layer indicates the presence of triterpenoids. 
 
5.3.5. TEST FOR GLYCOSIDES 
 Legal’s test 
1ml of pyridine and 1ml of sodium nitroprusside was added to 1ml of extract. 
Pink to red colour indicates the presence of glycosides. 
 Keller-Killiani test 
Glacial acetic acid was added to 2ml extract, followed by the addition of trace 
quantity of ferric chloride and 2 to 3drops of concentrated sulphuric acid. Reddish brown 
colour appears at the junction of two liquid indicates the presence of cardiac glycosides. 
 Baljet test: 
2ml of extract was  added to  sodium picrate solution. Yellow to orange colour 
formation indicates the presence of glycosides. 
 
5.3.6. TEST FOR STEROIDS AND STEROLS 
 Liebermann- Burchard reaction 
 2ml of extract was mixed with chloroform.  To that mixture added 1-2ml of 
acetic anhydride and 2drops of concentrated sulphuric acid along the sides of the test 
tube. The solution becomes red, then blue and finally bluish green colour. 
 Salkowski reaction 
2ml of extract was mixed with 2ml chloroform and 2ml concentrated sulphuric 
acid. Shaken well. Chloroform layer appears red and acid layer shows greenish yellow 
fluorescence. 
 
5.3.7. TEST FOR PHENOLS 
 Ferric chloride test 
1ml of the alcoholic solution of the extract was added to 2ml of distilled water 
followed by few drops of 10% ferric chloride. Formation of blue or green colour 
indicates the presence of phenols. 
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 Lead acetate test 
Diluted 1ml of alcoholic solution of extract with 5ml distilled water and to this 
added few drops of 1% aqueous solution of lead acetate. Formation of yellow colour 
precipitate indicates the presence of phenols. 
 
5.3.8. TEST FOR TANNINS 
 Lead acetate test 
A few drop of lead acetate was added to 5ml of aqueous extract. Formation of 
yellow or red colour precipitate indicates the presence of tannins. 
 
5.3.9. TEST FOR SAPONINS 
 Foam Test: 
1ml of test sample was diluted with 20ml of distilled water and shaken it in a 
graduated cylinder for 3minutes. Foam of 1cm after 10min indicates the presence of 
saponins. 
 Froth test: 
5ml of test sample was added to sodium bicarbonate solution. After vigorous 
shaking the mixture, kept it for 3minutes. A honey comb like froth formation indicates 
the presence of saponins. 
 
5.3.10. TEST FOR FLAVONOIDS 
 Alkaline reagent test 
A few drop of sodium hydroxide solution was added to the extract. Formation of 
an intense yellow colour, which turns to colourless on addition of few drops of dilute 
hydrochloric acid, indicates the presence of flavonoids. 
 
 Shinodas test [Magnesium hydrochloride reduction test] 
Alcoholic solution of extract was treated with a small piece of magnesium       
ribbon and a few drops of concentrated HCl was added and heated. Appearance of 
crimson red or occasionally green to blue colour infers the presence of flavonoid. 
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5.3.11 TEST FOR PROTEINS AND AMINO ACIDS 
 Biuret test 
3ml of test solution was added to  4% sodium hydroxide and few drops of 1% 
copper sulphate solution. Formation of violet colour indicates the presence of proteins. 
 Ninhydrin test 
A mixture of 3ml test solution and 3drops of 5% Ninhydrin solution was heated 
in a boiling water bath for 10min. Formation of purple or bluish colour indicates the 
presence of free amino acids.  
 
5.4. QUANTIFICATION OF TOTAL PHENOLICS AND FLAVONOIDS 
[45][46] 
5.4.1. ESTIMATION OF TOTAL PHENOLICS 
Reagents 
 Folin-Ciocalteu’s reagent 
 Gallic acid (1mg/ml) 
 20% sodium carbonate 
Preparation of standard 
 Standard solution of was prepared by adding 10mg of accurately weighed Gallic 
acid in 10ml of distilled water. 
Preparation of sample 
 10mg of the accurately weighed AQZR extract were separately dissolved in 10ml 
ethanol and used for the estimation. 
.Procedure 
The total phenolic content of the AQZR were determined by Folin-Ciocalteu 
assay method. To an aliquot 100μl of AQZR (1mg/ml) or  standard solution of Gallic 
acid (10, 20, 40, 60, 80, 100μg/ml) added 50μl of Folin-ciocalteu reagent followed by 
860μl of distilled water and the mixture is  incubated for 5min at room temperature. 
100μl of 20% sodium carbonate and 890μl of distilled water were added to make the 
final solution to 2ml. It was incubated for 30min in dark to complete the reaction. After 
that absorbance of the mixture was measured at 725nm against blank. Distilled water 
was used as reagent blank. The tests were performed in triplicate to get mean the values. 
The total phenolic content was found out from the calibration curve of Gallic acid. And it 
was expressed as milligrams of Gallic acid equivalents (GAE) per gram of extract. 
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5.4.2. ESTIMATION OF TOTAL FLAVONOIDS 
Reagents 
 Ethanol 
 10% Aluminium chloride 
 1M Potassium acetate 
Preparation of standard 
 Standard solution of was prepared by adding 10mg of accurately weighed 
Quercetin in 10ml of ethanol. 
Preparation of sample 
10mg of the accurately weighed AQZR extracts were separately dissolved in 
10ml ethanol and used for the estimation. 
Procedure 
The total flavonoid content of the AQZR was determined by using Aluminium 
chloride colorimetric method. To an aliquot of 100µl of extract (1mg/ml) or standard 
solutions of Quercetin (10, 20, 40, 60, 80, 100μg/ml) methanol was added separately to 
make up the solution upto 2ml.  The resulting mixture was treated with 0.1ml of 10% 
aluminium chloride, 0.1ml of 1M potassium acetate and 2.8ml of distilled water. Shaken 
well and incubated at room temperature for 30minutes. The absorbance was measured at 
415nm against blank, where a solution of 2ml ethanol, 0.1ml potassium acetate, 2.8ml 
distilled water and 0.1ml of aluminium chloride serve as blank solution. The total 
flavonoid content was determined from the standard Quercetin calibration curve. And it 
was expressed as milligrams of Quercetin equivalents (QE) per gram of extract. 
 
 
5.5. INVITRO ANTIOXIDANT STUDY OF AQZR 
5.5.1. DPPH Free Radical Scavenging Assay
  [47] 
 
Principle 
The DPPH [1, 1-diphenyl-2-picrylhydrazyl (α, α-diphenyl-β-picrylhydrazyl)] 
assay method is based on the reduction of DPPH, a stable free radical. The free radical 
DPPH with an odd electron gives a maximum absorption at 517nm (purple colour). 
When Antioxidants react with DPPH, which is a stable free radical becomes paired off in 
the presence of a hydrogen donor (e.g., a free radical scavenging antioxidant) and is 
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reduced to the DPPHH and as consequence the absorbance’s decreased from the DPPH.  
DPPH radical is a stable radical by virtue of the delocalization of the spare electron over 
the molecule as a whole, so that the molecules do not dimerize, as would be the case with 
most other free radicals. The delocalization also gives rise to the deep violet colour, 
characterized by an absorption band in ethanol/methanol solution centred at about 520nm 
Radical to the DPPH-H form, results in decolorization (yellow colour) with respect to the 
number of electrons captured. More the decolorization more is the reducing ability. This 
test has been the most accepted model for evaluating the free radical scavenging activity 
of any new drug. When a solution of DPPH is mixed with that of a substance that can 
donate a hydrogen atom, then this gives rise to the reduced form (Diphenyl picryl 
hydrazine;  non radical) with the loss of this violet colour (although there would be 
expected to be a residual pale yellow colour from the picryl group still present). 
Procedure 
The method adopted here is Blois method. Where by using the stable DPPH 
radical, the antioxidant capacity of the extract was measured in terms of hydrogen 
donating or radical scavenging ability. 1ml of 0.3mM solution of DPPH in ethanol was 
added to various concentrations of sample (10, 20, 40, 60, 80, 100 μg/ml) and the 
reference compound (5, 10, 15, 20, 25 and 30 μg/ml), shaken vigorously, and left to 
stand in the dark at room temperature. After 30 min absorbance was measured at 517nm 
against a blank. Quercetin was used as reference compound. A control reaction was also 
carried out without the test sample. All the tests were performed in triplicate in order to 
get the mean values. The percentage of inhibition was calculated by comparing the 
absorbance values of the control and test samples. Free radical scavenging activity was 
expressed as percentage inhibition (I%) and calculated using the following equation: 
 
Percentage inhibition (I%) = (Abs control- Abs sample /Abs control) X 100 
 
Different sample concentrations were used in order to obtain calibration curves 
and to calculate the IC50 values. (IC50 - concentration required to obtain a 50% radical 
scavenging activity). 
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5.5.2. ABTS Assay
  [48][49] 
Principle 
A method for the screening of antioxidant activity is reported as a decolorization 
assay applicable to both lipophilic and hydrophilic antioxidants, including flavonoids, 
hydroxyl cinnamates, carotenoids, and plasma antioxidants. The pre-formed radical 
monocation of 2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS*+) is 
generated by oxidation of ABTS with potassium persulfate and is reduced in the 
presence of such hydrogen-donating antioxidants present in the sample. The influences 
of both the concentration of antioxidant and duration of reaction on the inhibition of the 
radical cation absorption are taken into account when determining the antioxidant 
activity. Chemistry involves the direct generation of the ABTS radical monocation with 
no involvement of an intermediary radical. It is a decolorization assay; thus the radical 
cation is pre-formed prior to addition of antioxidant test systems, rather than the 
generation of the radical taking place continually in the presence of the antioxidant. An 
antioxidant with an ability to donate a hydrogen atom will quench the stable free radical 
and inhibits the absorption of the radical cation which has characteristic long-wavelength 
absorption spectrum showing maxima at 660,734, and 820nm.The relatively stable 
ABTS radical has a green colour and is quantified spectrometrically at 734nm. It is 
applicable to both aqueous and lipophilic systems. 
Procedure 
ABTS radical scavenging activity of the extract was measured by Rice-Evans 
method. ABTS was dissolved in water to a 7mM concentration. ABTS radical cation 
(ABTS+) was produced by reacting ABTS stock solution with 2.45mM potassium 
persulfate and allowing the mixture to stand in the dark at room temperature for 12- 16hr 
before use. The radical was stable in this form for more than 2 days when stored in the 
dark at room temperature. For the study, ABTS solution was diluted with phosphate 
buffer saline pH 7.4 (PBS) to an absorbance of 0.70 (± 0.02) at 734nm and equilibrated 
at 30
0
C. After addition of 1ml of diluted ABTS solution to various concentrations of 
sample or reference compound (Quercetin), the reaction mixture was incubated for 6min 
and then absorbance was measured at 734nm against a blank. A control reaction was 
carried out without the sample. All the tests were performed in triplicate in order to get 
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the mean values. The percentage inhibition of ABTS+ by the sample was calculated 
according to the formula: 
 
Percentage inhibition (I %) = (Abs control- Abs sample /Abs control) X 100 
            
            Different sample concentrations were used in order to obtain calibration curves 
and to calculate the EC50 values. (EC50 - concentration required to obtain a 50% radical 
scavenging activity). 
 
5.5.3. Nitric Oxide Assay 
[50][51] 
Principle :  
              Nitric oxide (NO) and reactive nitrogen species (RNS) are free radicals are 
derived from the interaction of NO with oxygen or reactive oxygen species. Nitric oxide 
is classified as a free radical because of its unpaired electron and displays important 
reactively with certain types of proteins and other free radical such as superoxide. NO is 
synthesized by three isoforms of the enzymatic nitric oxide synthase (NOS), endothelial 
NOS, neuronal NOS, and inducible NOS (iNOS). Nitric oxide (NO) is generated from 
amino acid L-arginine by the enzymes in the vascular endothelial cells, certain neuronal 
cells, and phagocytes.  Low concentration of NO are sufficient in most cases to affect the 
physiological function of the radical.  NO is a diffusible free radical that plays many 
roles as an effectors molecule in diverse biological systems including neuronal 
messenger, vasodilation and antimicrobial and antitumor activities. Chronic exposure to 
nitric oxide radical is associated with various carcinomas and inflammatory conditions 
including juvenile diabetes,  multiple sclerosis, arthritis and ulcerative colitis. The 
toxicity of NO increases greatly when it react with the superoxide radical, forming the 
highly reactive peroxy nitrite anion (ONOO
-
 ).  Nitric oxide has been shown to be 
directly scavenged by flavonoids. 
 
Procedure:  
        The nitric oxide scavenging activity was conducted based on the Greiss assay 
method. 2.0 mL of 10 mM sodium nitroprusside and 0.5mL of phosphate buffer were 
mixed with 0.5mL of different concentration of the plant extract and incubated at 25ºC 
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for 150 min. The sample was run as above but the blank was replaced with the same 
amount of water. After the incubation period, 2ml of the above incubated solution was 
added to 2ml of Griess reagent and incubated at room temperature for a period of 
30mins. The absorbance of the chromophore formed was read at 540nm.  
 
Percentage inhibition (I%) = (Abs control- Abs sample /Abs control) X 100 
 
5.6 ANTI-MICROBIAL ACTIVITY OF AQZR 
[52] 
5.6.1. Antibacterial study of AQZR 
Preparation of inoculums 
The inoculums for the experiment were prepared in fresh nutrient broth from the 
preserved slant culture. The turbidity of the culture can be adjusted by the addition of 
broth or sterile saline (if it is excessive) or by further incubation to get the required 
turbidity, and the newly prepared inoculums were standardized by adjusting the turbidity 
of the culture to that of McFarland standards. 
Preparation of sterile swabs 
Cotton wool swab on wooden applicator or plastics were prepared and sterilized 
by autoclaving or by dry heat (only for the wooden swabs). It was sterilized by packing 
the swabs in culture tubes, papers or tins etc. 
Sterilization of forceps 
 Forceps can be sterilized by dipping in alcohol and burning off the alcohol. 
Experiment 
The standardized inoculums is inoculated in the sterilized plates prepared earlier 
(aseptically) by dipping a sterile in the inoculums removing the excess of inoculums by 
passing and rotating the swab firmly against the side of the culture tube above the level 
of the liquid and finally streaking the swab all over the surface of the medium 3times 
rotating the plate through an angle of 60º after each application. Finally pass the swab 
round the edge of the agar surface. Leave the inoculums to dry at room temperature with 
the lid closed. The sterile discs are soaked overnight in sample solutions, AQZR. Each 
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petri dish is divided into 2 parts. First compartment were loaded with sample disc as 
AQZR (100µg) and second compartment with standard Ciprofloxacin disc (10µg) with 
the help of sterile forceps. After that petri dishes are placed in the refrigerator at 4º C or 
at room temperature for 1hour for diffusion. Incubate at 37ºC for 24hours. Observe the 
zone of inhibition produced by different samples. Measure it using a scale and record the 
average of two diameters of each zone of inhibition. 
          
                      Table 2: Bacterial strain used for the study with NCIM 
 
Sl no Organism Strain NCIM 
1  
Gram+ve    
bacteria 
Bacillus subtilis 2063 
2 Staphylococcus aureus 2079 
3  
Gram–ve 
bacteria 
E-coli 2065 
4 Pseudomonas auregenosa        2200 
 
5.6.2. Anti fungal activity of  AQZR 
Procedure 
Preparation of inoculums 
The inoculums for this particular experiment were prepared in fresh sabouraud 
dextrose broth from preserved slant culture. The turbidity of the culture can be adjusted 
by the addition of broth or sterile saline (if it is excessive) or by further incubation to get 
the required turbidity, and the newly prepared inoculums were standardized by adjusting 
the turbidity of the culture to that of McFarland standards. 
Preparation of sterile swabs 
Cotton wool swab on wooden applicator or plastics were prepared and sterilized 
by autoclaving or by dry heat (only for the wooden swabs). It was sterilized by packing 
the swabs in culture tubes, papers or tins etc. 
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Sterilization of forceps 
Forceps can be sterilized by dipping in alcohol and burning off the alcohol. 
Experiment 
The standardized inoculums is inoculated in the sterilized plates prepared earlier 
(aseptically) by dipping a sterile in the inoculums removing the excess of inoculums by 
passing and rotating the swab firmly against the side of the culture tube above the level 
of the liquid and finally streaking the swab all over the surface of the medium 3times 
rotating the plate through an angle of 60º after each application. Finally pass the swab 
round the edge of the agar surface. Leave the inoculums to dry at room temperature with 
the lid closed. The sterile discs are soaked overnight in sample solutions, AQZR. Each 
Petri dish is divided into 2 parts. First compartment were loaded with sample disc as 
AQZR (100µg) and second compartment with standard Fluconazole disc (10µg) with the 
help of sterile forceps. After that petri dishes are placed in the refrigerator at 4ºC or at 
room temperature for 1hour for diffusion. Incubate at 37ºC for 24hours. Observe the 
zone of inhibition produced by different samples. Measure it using a scale and record the 
average of two diameters of each zone of inhibition. 
 
                         Table 3: Fungal strain used for the study with MTCC 
 
Si no Fungi strains used MTCC 
1 
 
Aspergillus niger  1344 
2 Monascus purpureus 1090 
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5.6.3. DETERMINATION OF MINIMUM INHIBITORY CONCENTRATION OF 
AQZR 
[53][54] 
The minimum inhibitory concentration (MIC) is the lowest concentration of a 
chemical that prevents the visible growth of the organism.ie, the lowest concentration at 
which it has bacteriostatic activity. 
5.6.3.1. Preparation of test drug: 
The selected test drugs were prepared in DMSO at a concentration 2000µg/ml  
5.6.3.2. Preparation of inoculums: 
Bacillus subtilis, Staphylococcus aureus, E-coli, Pseudomonas auregenosa, Aspergillus 
niger, and Monascus purpureus were the strains of organisms selected for the study. 
Overnight culture are grown at 37
0
C Kirby- Bauer procedure and diluted to Muller 
Hinton Broth and Sabouraud Dextrose Broth for bacterial and fungal strains respectively. 
This overnight culture was diluted to 10
-2
. 
Inoculation 
1. The sterile tubes were labeled 1-8 and 8th tube was taken as control. 
2. 1ml of Muller Hinton Broth was transferred to all tube. 
3. 1ml of drug solution was added to 1st tube and mixed well. 
4. From the 1st tube transfer 1ml of solution to the 2nd tube and was repeated up to 
7
th 
tube. 
5. From the 7th tube 1ml of solution was pipette out and discarded. 
6. 0.01ml of culture was added to all the test tubes. 
7. All the tubes were incubated at 370C for 18-24hrs. 
8. After incubation observe the turbidity by visually 
9. The highest dilution without growth is the minimal inhibitory concentration. 
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5.7. .PHARMACOLOGICAL EVALUATION OF AQZR 
5.7.1. ACUTE TOXICITY STUDY 
[55] 
Based on previously conducted study the dose was selected. 
  
5.7.2. ANIMALS AND MANAGEMENT 
Female Wistar rats of 6-8 weeks old and 160-180g body weight were offered by 
KMCH College of Pharmacy, Coimbatore. All rats were kept at room temperature and 
allowed to accommodate in standard conditions at 12-hr light and 12-hr dark cycle in the 
animal house. Animals were fed with commercial pellet diet and water  ad libitum freely 
throughout the study. The experimental procedure was approved by IAEC (Institutional 
animal ethical committee of KMCH, governed by CPCSEA, Government of India.  
 
5.7.3. DRUG 
Commercially available Povidone Iodine Ointment (5%) were used as standard 
drug. The ointments were applied topically over the wound area. 
 
5.7.4. PREPARATION OF TEST DRUG 
AQZR ointment was formulated using (1%) AQZR stem extract in simple base 
ointment. 
 
5.7.5. PREPARATION OF SIMPLE OINTMENT BASE 
 [56] 
Ingredients: 
 Wool fat    5.0g  
 Hard paraffin   5.0g  
 Cetostearyl alcohol  5.0g 
 White soft paraffin  85.0g 
Type of preparation: Absorption ointment base 
Procedure: 
 Hard paraffin and cetostearyl alcohol taken in a china dish kept on water-bath at 
70
0
C. Wool fat and white soft paraffin are added to this mixture and stirred until all the 
ingredients are melted. If required decanted or strained and stirred until cold and packed 
in suitable container. 
1% of AQZR were separately mixed with the above prepared simple ointment base. 
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5.7.6. EXPERIMENTAL MODEL 
5.7.7. EVALUATION OF WOUND HEALING EFFECT OF AQZR IN                 
EXCISION WOUND MODEL 
 
Rats were divided into 4 groups each containing 5 animals as follows. 
 
Table 4: Experimental design for excision wound model 
 
GROUP 
GROUP 
SPECIFICATION 
INTERVENTION 
Group I Control Untreated 
Group II Simple base ointment  
Only with simple base 
ointment  
Group III Standard 
Povidone iodine 
ointment 5% 
Group IV Test 1 AQZR ointment 1% 
 
INDUCTION OF WOUND 
[57] 
             On wounding day the rats were anaesthetized prior to creation of the wounds, by 
ether anaesthesia. The dorsal fur of the animal was shaved with an electric clipper and 
the area of the wound to be created was outlined on the back of the animals with 
methylene blue using a circular stainless steel stencil. A full thickness of the excision 
wound of 1.5cm in width (circular area 2.25cm
2
) created along the markings using 
toothed forceps, a surgical blade and pointed scissors. The entire wound left open. All 
the surgical interventions were carried out under sterile condition. After 24h of  wound 
creation, the ointments was applied gently to cover the wounded area once daily until 
complete healing Wound area and wound contraction, epithelializtion period and 
hydroxyproline content were monitored. 
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5.8. ESTIMATION OF PARAMETERS 
 
5.8.1. Measurement of wound contraction 
[58] 
The progression of wound healing was judged by the periodic assessment of the 
contraction of excision wounds. Wound contraction was monitored by tracing the outline 
of the wound on tracing sheet and then using graph sheet to calculate the area of the 
wound size. All animals in each group were monitored until complete healing of wounds 
occurred and the day at which each wound healed was recorded. Mean of all healed 
wounds was determined. 
 
Percent wound contraction =    Healed area   × 100 
                                                  Total area 
 
5.8.2. Estimation of hydroxyproline 
[59][60] 
Principle 
The procedure is based on alkaline hydrolysis of the tissue homogenate and 
subsequent determination of the free hydroxyproline for the production of a pyrole. The 
addition of Ehrlich's reagent resulted in the formation of achromophore that can be 
measured at 557nm. Optimal assay conditions were determined using tissue homogenate 
and purified acid soluble collagen along with standard hydroxyproline. Critical 
parameters such as the amount of chloramine-T, sodium hydroxide,              p-
dimethylaminobenzaldehyde, pH of the reaction buffer, and length of oxidation time 
were observed to obtain satisfactory results. 
 
Procedure 
Known amount of tissue (50mg) was taken in glass tubes and 4ml of 6N HCl was 
added to each tube to hydrolyse the tissue sample. The glass tubes were sealed and were 
incubated for 22 hours. The tubes are then opened and the contents are decanted into a 
china dish. HCl was then removed by evaporation and the residue was dissolved in water 
and made up to known volume (10ml) using a standard flask. A series of standards were 
prepared containing 20-200μg of hydroxyproline with a final volume of 2ml. 1ml of the 
hydrolyzed tissue samples was used to estimate the contents of hydroxyproline. 
Hydroxyproline oxidation was initiated by adding 1ml of chloramine-T to each tube in a 
predetermined sequence. The tube content were mixed by shaking a few minutes and 
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allowed to stand for 20min at room temperature. Chloramine-T was then destroyed by 
adding 1ml of perchloric acid to each tube in the same order as before. The contents were 
mixed and allowed to stand for 5min. Finally 1ml of p-Dimethyl aminobenzaldehyde 
solution was added and the mixture was shaken well. Tubes were placed in a 60°C water 
bath for 20min and then cooled in tap water for 5min. The colour developed was read 
spectrophotometrically at 557nm. Hydroxyproline value was determined from the 
standard curve. 
 
5.8.3 Estimation of Hexosamine 
[59] [61] 
Principle 
The method was based on the observation that in alkaline solution at 100°C, the 
amino sugars react with acetyl acetone to form chromogenic material which gives a 
chromophore or chromophores on treatment in acid solution with ethanolic p-dimethyl 
amino benzaldehyde. The method described is suitable for the estimation only for free 
amino sugars where a determination is carried to as certain the amino sugar content of a 
polysaccharide or other material of high molecular weight. Any amino sugar units 
remaining as oligosaccharide or substituted aminosugar gives less color per unit weight 
of amino sugar than that found for free amino sugar. Therefore it is essential that the 
hydrolysis of granulation tissue is done without destruction of the amino sugar. 
 
Procedure 
        Tissue samples (50mg) were hydrolyzed with 2NHCL (5ml) at 100°C for  
6hrs. Hydrochloric acid was then removed by evaporation, then the residue was 
dissolved in water and made up to a known volume (10ml) using a standard flask. 
Aliquots containing 10-50mg hexosamine were treated with 1ml of freshly prepared 2% 
acetyl acetone in 0.5M sodium carbonate in capped tubes and kept in boiling water bath 
for 15min. After cooling in tap water, 5ml of 95% ethanol and 1ml of Ehrlich's reagent 
(1.33%Dimethyl amino benzaldehyde in 1:1 ethanol: concentrated hydrochloric acid 
mixture) were added and mixed thoroughly. The purple red colour developed was read 
after 30min at 530 nm. Water blank and standard glucosamine solution of various 
concentrations were also treated similarly to get a standard curve. 
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5.8.4. Estimation of Uronic acid 
[59][62] 
 
Principle 
The galacturonic acid content of the hydrolyzed sample is quantified 
colorimetrically using a modification of the Copper reduction procedure originally 
described by Avigad and Milner. This modification, substituting the commonly used 
Folin-Ciocalteu reagent for the arsenic containing Nelson reagent, gives a response that 
is linear, sensitive, and selective for uronic acids over neutral sugars. This method also 
avoids the use of concentrated acids needed for the commonly used m-phenyl phenol 
method. This combined enzymatic and colorimetric procedure correctly determined the 
galacturonic acid and methanol content of purified sample. In both cases good agreement 
was obtained between this method and commonly used methods. 
 
Procedure 
A buffered copper solution was prepared by adding 23.2g NaCl, 3.2g sodium 
acetate, and 1ml glacial acetic acid to 80ml water. Once dissolved, 0.5g CuSO4 is added, 
the pH adjusted to 4.8 with NaOH, and the final volume brought to 100ml. This solution 
is stable for weeks at room temperature. For the assay, equal volumes of this solution and 
the sample are mixed, giving final reagent concentrations in the assay of 2M NaCl, 0.2M 
acetate, and 10mM CuSO4. In our standard assay, sample and assay solution volumes of 
0.1ml each are mixed in test tubes, then the tubes are covered with glass marbles and 
placed in an aluminum heating block at 100 C. A diluted Folin–Ciocalteu reagent is then 
prepared by mixing 1ml of 2N Folin–Ciocalteu with 39ml of water. After 40min, the 
samples are removed from the heat and 8 volumes (0.8ml in our standard assay) of the 
40-fold diluted Folin–Ciocalteu reagent is added. A colored product forms immediately; 
absorbance was measured at 750nm. Where the BCA reagent was used the procedure 
was the same, except instead of adding the diluted Folin– Ciocalteu reagent, 0.8mL of 
solution ‘‘A” from the procedure described in Waffenschmidt and Jaenicke, containing 
5.0mM BCA in pH 10.1 carbonate buffer, was added. Absorbance was measured at 
560nm. 
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5.9. HISTOLOGICAL ASSESSMENT
 [59]
 
Histological studies of wounded tissues provide accurate diagnosis of level of 
healing of the wound. Histopathology is the microscopical study of tissues for 
pathological alterations. This involves collection of morbid tissues from biopsy or 
necropsy, fixation, preparation of sections, staining and microscopical examination. 
 Collection of materials 
 Thin pieces of 3 to 5mm, thickness were collected from tissues showing gross 
morbid changes along with normal tissue. 
 Fixation: 
 Kept the tissue in fixative for 24-48hours at room temperature 
The fixation was useful in the following ways: 
a) Serves to harden the tissues by coagulating the cell protein, 
b) Prevents autolysis, 
c) Preserves the structure of the tissue, and  
d) Prevents shrinkage  
Common Fixatives: 10% Formalin                             
5.10. STATISTICAL ANALYSIS 
Data’s of all the parameters were analyzed using the Graph pad 5.0 software. 
Analysis of Variance (ANOVA); one way ANOVA followed by Dunnets comparison 
test was performed. The values were expressed as Mean ± SEM. P value<0.05 was 
considered as significant. 
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6. RESULTS 
 
6.1 EXTRACTIVE YIELD OF AQUEOUS STEM EXTRACT OF Zanthoxylum 
rhetsa (Roxb.) DC 
Percentage Yield:  
Coarsely powdered Zanthoxylum rhetsa (Roxb) DC stem were extracted with aqueous 
using maceration technique. 
The percentage yield of Aqueous stem extract of Zanthoxylum rhetsa (Roxb)DC (AQZR) 
was found to be 14 % w/w. 
 
6.2 PRELIMINARY PHYTOCHEMICAL ANALYSIS OF AQZR 
Table 5: Phytochemical Analysis of Zanthoxylum rhetsa (Roxb) DC 
 
 
  
S.NO 
PHYTOCHEMICAL 
CONSTITUENTS 
AQZR 
1 Alkaloids Positive 
2 
Proteins and           
Aminoacids 
Positive 
3 Flavonoids Positive 
4 Phenols Positive 
5 Glycosides Positive 
6 Tannins Positive 
7 Carbohydrates Positive 
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6.3 QUANTIFICATION OF TOTAL PHENOL AND FLAVONOIDS 
6.3.1 ESTIMATION OF TOTAL PHENOL OF AQZR 
 
Table 6: Estimation of total phenolic content of AQZR 
Sample Concentration (µg/ml) Absorbance 
Standard 
(Gallic acid) 1mg/ml 
10 0.087 
20 0.118 
40 0.205 
60 0.336 
80 0.401 
100 0.495 
AQZR 100 0.3185 
 
 
Figure 2: Estimation of total phenolic content of AQZR 
 
The total phenolic content in AQZR was found to be 71.37mg/g of extract 
calculated as Gallic acid equivalent. 
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6.3.2 ESTIMATION OF TOTAL FLAVONOID CONTENT OF AQZR 
Table 7: Estimation of total flavonoid content of AQZR 
Sample Concentration (µg/ml) Absorbance 
Standard 
(Quercetin) 
1mg/ml 
10 0.031 
20 0.085 
40 0.26 
60 0.5026 
80 0.776 
100 1.053 
AQZR 100 0.7046 
 
 
Figure 3: Estimation of total flavonoid content of AQZR 
 
The total flavonoid content in AQZR was found to be 40.64 mg/g of extract 
calculated as Quercetin equivalent. 
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6.5 IN VITRO ANTIOXIDANT ACTIVITY OF AQZR 
 
6.5.1 DPPH RADICAL SCAVENGING ACTIVITY 
Table 8: Percentage inhibition and IC50 values of DPPH radical by Quercetin 
Sl.No Concentration (µg/ml) 
Percentage 
inhibition 
IC50(µg/ml) 
1 5 41.2 
 
1.55 
 
 
2 10 55.7 
3 15 69.4 
4 20 86.4 
5 25 96.5 
6 30 99.38 
 
Fig 4: DPPH radical scavenging activity of Quercetin 
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Table 9: Percentage inhibition and IC50 values of DPPH radical by AQZR 
Sl.No Concentration (µg/ml) 
Percentage 
inhibition 
IC 50(µg/ml) 
1 10 26.69 
      17.77 
2 15 43.89 
3 20 50.12 
4 25 59.67 
5 50 69.77 
6 100 91.36 
 
Fig 5: DPPH radical scavenging activity of AQZR 
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6.5.2 TOTAL ANTIOXIDANT ACTIVITY BY ABTS RADICAL CATION ASSAY 
Table 10: Percentage inhibition and IC50 values of ABTS radical by Quercetin 
Sl.No Concentration (µg/ml) 
Percentage 
inhibition 
IC50(µg/ml) 
1 0.25 70.08 
    0.1142 
2 0.5 75.22 
3 0.75 79.62 
4 1.0 85.88 
5 1.25 91.9 
6 1.75 98.85 
 
Fig 6: ABTS radical scavenging activity of  Quercetin 
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Table 11: Percentage inhibition and IC50 values of ABTS radical by AQZR 
Sl.No Concentration (µg/ml) 
Percentage 
inhibition 
IC50 (µg/ml) 
1 1 53.61 
 
1.160 
 
2 2 57.41 
3 3 61.63 
4 4 71.18 
5 5 76.92 
6 10 97.37 
 
Fig 7: ABTS radical scavenging activity of AQZR 
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6.5.3 NITRIC OXIDE RADICAL SCAVENGING ACTIVITY 
Table 12: Percentage inhibition and IC50 values of NO radical by Quercetin 
Sl.No 
Concentration 
(µg/ml) 
Percentage 
inhibition 
IC50(µg/ml) 
1 1 41.2  
 
               1.55 
2 2 55.7 
3 3 69.4 
4 4 86.4 
5 5 96.5 
  
Fig 8: NO radical scavenging activity of Quercetin 
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Table 13: Percentage inhibition and IC50 values of NO radical by AQZR 
Sl.No 
Concentration 
(µg/ml) 
Percentage 
inhibition 
IC50 (µg/ml) 
1 10 24  
 
30.5 
2 20 35.9 
3 30 49,7 
4 40 66.4 
5 50 74.8 
 
Fig 9: NO radical scavenging activity of AQZR 
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6.6 ANTI MICROBIAL ACTIVITY OF AQZR 
ANTI BACTERIAL ACTIVITY 
Table 14: Zone of inhibition for Gram +ve organisms 
Sino Gram +ve organisms Standard 
Ciprofloxacin(mm) 
AQZR(mm) 
1 Bacillus subtilis 25 10 
2 Staphylococcus aureus 26 14 
 
Figure 10: Zone of inhibition for Gram +ve organisms 
 
 
Table 15: Zone of inhibition for Gram –ve organisms 
Sino Gram –ve organisms Standard 
Ciprofloxacin(mm) 
AQZR(mm) 
1 E.coli 26 9 
2 Pseudomonas auregenosa 27 10 
  
 
Staphylococcus aureus                     Bacillus subtilis 
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Figure 11: Zone of inhibition for Gram –ve organisms 
 
 
ANTIFUNGAL ACTIVITY OF AQZR 
Table 16: Antifungal activity of AQZR 
Sino                   Organisms Standard 
Fluconazole(mm) 
AQZR(mm) 
   1 Aspergillus niger 21  12  
2 Monascus purpureus   24   15  
 
Figure 12: Antifungal activity of AQZR 
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6.6.1 MINIMUM INHIBITORY CONCENTRATION OF AQZR 
BACTERIAL ORGANISMS 
Table 17: MIC values of AQZR 
SI NO         GRAM +VE  &  GRAM –VE                     
ORGANISMS  
MIC VALUE OF     
AQZR  
  1                 Bacillus subtilis (µg/ml)    250  
  2                Staphylococcus aureus  (µg/ml)  125  
  3               E.coli  (µg/ml)   125  
   4            Pseudomonas auregenosa (µg/ml) 125  
 
Figure 13: MIC of AQZR 
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FUNGAL ORGANISMS 
Table 18: MIC values of AQZR 
SI NO FUNGAL ORGANISMS 
 
MIC VALUE    OF   
AQZR 
1 Aspergillus niger  (µg/ml) 250 
2 Monascus purpureus (µg/ml) 250 
 
 
Figure 14: MIC of AQZR 
 
 
 
 
 
 
 
 
  
Results 
 
Dept. of Pharmacology, KMCH College of Pharmacy                                                           52 
 
6.8 PHARMACOLOGICAL STUDIES 
6.8.1 EVALUATION OF WOUND HEALING EFFECT OF AQZR IN EXCISION 
WOUND MODEL  
Figure 15: Percentage wound contraction on excision wound model 
On 1
st
 day 
                                                   
  Control             Simple base ointment               Standard                           AQZR 
 
On 21
st
 day 
                                                 
   
Control                 Simple base ointment           Standard                            AQZR 
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6.9. ESTIMATION OF PARAMETERS 
6.9.1. PERCENTAGE WOUND CONTRACTION 
Table 19: Percentage wound contraction in excision wound model 
 
COMPOUNDS  
0
th
Day  3
rd
Day  7
th
Day  13
th
Day   17
th
Day   19
th
Day  
% WC  % WC  % WC  % WC  % WC    % WC  
CONTROL   0  27.5±0.58  23.6±2.03  74.2±0.99  72±0.99  85.1±0.99  
SIMPLE  BASE 
OINTMENT  
 0  
13.5±0.49  27±0.83  52.5±1.24  66.8±1.24  88.2±1.88  
STANDARD  0  15.7±0.29  39.8±0.77  81.8±1.09  88.5±1.25  99.5±1.10  
AQZR OINTMENT  0  10±0.42  13.8±1.48  55.4±1.08  84.1±1.08  96.9±1.08  
 
Figure 16: Effect of AQZR on % wound contraction in excision wound model
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6.9.2 ESTIMATION OF HYDROXYPROLINE 
Table 20: Hydroxyproline levels in excision wound models. 
 
GROUP 
 
   HYDROXY PROLINE (µg/g)  
Control 36.64±2.107 
Simple base ointment  39.00±3.123
ns
 
Standard 81.12±3.142
*** 
AQZR 70.11±2.010
**
 
 
Statistical comparison Each group (n=5), each value represents mean ± SEM. One way 
Anova  was performed  
***
P<0.001,
 **
P<0.01,
 *
P<0.05,when all groups compared with 
control. 
 
Figure 17: Effect of AQZR on Hydroxyproline level in excision wound model 
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6.9.3 ESTIMATION OF HEXOSAMINE 
Table 21: Hexosamine levels in excision wound model. 
 
GROUP 
 
HEXOSAMINE (µg/g) 
Control 73.81±1.271 
Simple base ointment  79.81±1.701
 ns
 
Standard 88.12±1.412
***
 
AQZR 85.10±1.812
**
 
 
Statistical comparison Each group (n=5), each value represents mean ± SEM. One way 
Anova was performed 
***
P<0.001,
 **
P<0.01,
 *
P<0.05, when all groups compared with 
control. 
 
Figure 18: Effect of AQZR on Hexosamine level in excision wound model 
 
C
on
tr
ol
S
im
pl
e 
oi
nt
m
en
t
S
ta
nd
ar
d
A
Q
ZR
0
20
40
60
80
100
       ***
  **
ns
Groups
H
e
x
o
s
a
m
in
e
 M
g
/1
0
0
m
g
 t
is
s
u
e
  
Results 
 
Dept. of Pharmacology, KMCH College of Pharmacy                                                           56 
 
 
6.9.4. ESTIMATION OF URONIC ACID 
Table 22: Uronic acid levels in excision wound model. 
 
GROUP 
 
                  URONIC ACID (µg/g) 
Control 17.12±0.412 
Simple base ointment  19.41±0.481
 ns
 
Standard 50.17±0.644
***
 
AQZR 42.49±0.556
**
 
 
Statistical comparison Each group (n=5), each value represents mean ± SEM. One way 
Anova followed by Dunnets test was performed
***
P<0.001,
 **
P<0.01,
 *
P<0.05,when all 
groups compared with control. 
            Figure 19: Effect of  AQZR on Uronic acid level in excision wound model 
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6.10. HISTOPATHOLOGICAL STUDY 
           Histopathological evaluation of excision wound model. 
Figure 20: Group 1- Control 
 
The section of the skin and epidermis shows incomplete healing with less 
epithelialization and lesser collagen formation indicated the incomplete wound healing. 
 
                                  Figure  21: Group 2- Simple base ointment  
 
The section of the skin and epidermis shows incomplete healing. Section of the skin and 
epidermis shows proliferation of fibroblasts 
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                                               Figure 22 : Group 3- Standard 
 
 
Section of the epidermis shows Re-epithelialization with the proliferation of fibroblasts 
and few lymphocytes in the sub epithelium with thin walled congested blood vessels. 
 
Figure 23: Group 4 - AQZR treated 
 
 
Section of the epidermis shows Re-epithelialization with the proliferation of fibroblasts, 
of dense fibrous tissue and blood capillaries was observed. Few macrophages were also 
present. 
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                                         7. DISCUSSION 
Wound is a clinical entity and is as old as mankind, often considered as major 
problem in clinical practice.  Each year, millions of people experience burns, suffer from 
chronic wounds, or have acute wounds that become complicated by infection, dehiscence 
or problematic scarring. Wounds are normally resolved in a few days, but chronic 
wounds represent a major burden because of economic and social factors. There by, the 
search for new agents is ongoing and natural products become a great target. Individual 
factors such as stress or diabetes can cause delays in the healing process or increase the 
risk of infection in the wound. Due to unawareness of the society this may lead to 
chronic diseases which may damage the other organs. Impaired wound healing can result 
into severe morbidity leading to long hospitalization of patients. States (US) population, 
which results in a significant economic burden estimated to be nearly 2–4% of the health 
budgets. 
Zanthoxylum rhetsa (Roxb) DC the paradise tree has a long history in herbal 
medicine in various countries. The bark, seed, and stem extract of Zanthoxylum rhetsa  is 
well known for its different types of pharmacological properties such as Digestive 
problem, Inflammatory dermatosis, Tooth ache, Cytotoxic properties,                      
Antinociceptive, Antioxidant, Antibacterial, Antifungal.  Externally it is used for wound 
healing. The major active constituents are budrungaine, budrungainine, rhetine, rhetsine, 
evodiamine, chelerythrine, lupeol. The present study was aimed to evaluate the wound 
healing potential of aqueous stem extract of Zanthoxylum rhetsa in excision wound 
model of rats. 
Phytochemical screening of AQZR were performed and the results revealed the 
presence of alkaloids, proteins and amino acids, flavonoids, tannins, phenols, glycosides, 
tannins, carbohydrates. The main attraction of the phytochemical was the presence of 
phenols and flavonoids which was concluded by the colorimetric estimation of these 
constituents in the extract. 
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Flavonoids are coming under the category of polyphenols, where its action is 
mainly attributed to anti-inflammatory action and it provides a symptomatic relief in 
wound. 
 
Phytopharmaceuticals are gaining importance in modern medicine as well as in 
traditional system of medicine owing to their therapeutic effect due to the presence of 
phytochemicals such as polyphenols, flavonoids, terpenoids etc.  
 
Flavonoids are wide spread plant secondary metabolites that have shown free 
radical scavenging activity and protection against oxidative stress. Studies were revealed 
that flavonoids are also known to promote the wound healing process mainly due to their 
astringent and antimicrobial properties which appear to be responsible for the wound 
healing and increased rate of epithelialization. Polyphenols are the major plant 
compounds with antioxidant activity that is mainly due to their redox properties which 
enables them to act as reducing agents, hydrogen donors and singlet and triplet oxygen 
scavengers. Results obtained in the present study revealed that the levels of these 
phytoconstituents were considerable and the total phenol and flavonoid content was 
found to AQZR-71.37mg/g and AQZR-40.64mg/g respectively. 
Antioxidants are compounds that inhibit or delay the oxidation of other molecules 
by inhibiting the initiation or propagation of oxidizing chain reactions. They are radical 
scavengers which protect the human body against free radicals that may cause 
pathological conditions such as ageing, dementia, cancer etc. Therefore in the present 
study, the potential of the AQZR to serve as antioxidants was assayed. 
Free-radicals play an important role in the oxidative damage of biological 
systems. Several complementary methods have been adopted to trap free radicals 
through antioxidant activity, among which DPPH* assay is the most common. The effect 
of antioxidants on DPPH is thought to be due to their hydrogen donating ability. The free 
radical scavenging activity of the extract was estimated by comparing the % inhibition of 
AQZR with standard Quercetin. IC50 was also calculated to determine the amount of 
extract needed to quench 50% of radicals.  Stem extract of Zanthoxylum rhetsa exhibited 
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a dose dependent scavenging activity with IC50 values of, 17.77 µg/ml respectively for 
AQZR. Where the IC50 for standard Quercetin was found to be 1.55 µg/ml. 
 
           The ABTS+ scavenging assay, which employs a specific absorbance (734nm) at a 
wavelength remote from the visible region and requires a short reaction time, can be used 
as an index that reflects the antioxidant activity of the test samples. The presence of 
specific chemical compounds in the extracts of Zanthoxylum rhetsa  may inhibit the 
potassium persulfate activity and hence reduced the production of ABTS+. Zanthoxylum 
rhetsa extracts were found to be effective in scavenging radicals and the increase was 
concentration-dependent.  IC50 value of Quercetin was 0.1142 µg/ml whereas 1.160 
µg/ml for AQZR respectively. This shows that Zanthoxylum rhetsa  stem extract presents 
a good ability to scavenge the ABTS radical.  
The NO scavenging assay, which employs a specific absorbance (546nm) at a 
wavelength remote from the visible region and requires a short reaction time, can be used 
as an index that reflects the antioxidant activity of the test samples.  Zanthoxylum rhetsa 
extracts were found to be effective in scavenging radicals and the increase was 
concentration-dependent.  IC50 value of Quercetin was 1.55µg/ml whereas 30.5 µg/ml for 
AQZR respectively. This shows that Zanthoxylum rhetsa extract presents a good ability 
to scavenge the NO radical. The antioxidant activities against ABTS, DPPH and NO 
were correlated with the concentration, chemical structures, and polymerization degrees 
of organ antioxidants. 
            Thus from the result obtained it could be concluded that AQZR shows a good 
antioxidant activity which might be attributed to the presence of phytochemicals such as 
polyphenols and flavonoids. 
The antimicrobial study was carried out aqueous extract of Zanthoxylum rhetsa 
against different strain of bacteria (2 Gram + ve and 2 Gram – ve) and fungi      (2 
strains), that are known to cause infection in human and plants, by disc diffusion method 
at 200µg/disc. The ciprofloxacin 10µg/disc and fluconazole 10µg/disc were used as 
standard for bacteria and fungi respectively.  
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The standard ciprofloxacin and fluconazole was found to have significant 
antimicrobial activity against bacteria and fungi respectively. The various zones of 
inhibition were observed from all the extracts against various strains. Among the extracts 
the AQZR was observed to have significant antimicrobial activity. The zone of inhibition 
was observed from Gram +ve and Gram –ve bacteria and fungi strains. The maximum 
zone of inhibition (14mm) was found in AQZR of Zanthoxylum rhetsa against 
Staphylococcus aureus for the Gram +ve organism and for Gram –ve organisms the 
maximum zone of inhibition (10mm) was found in AQZR against Pseudomonas 
auregenosa.   
 The extract showed antifungal activity, the antifungal activity was observed 
maximum in AQZR. Among all, the zone of inhibition was found to be maximum for 
Monascus purpureus (15mm). 
Minimum Inhibitory Concentration (MIC) is defined as the highest dilution or 
least concentration of the extracts that inhibit growth of organisms. Determination of the 
MIC is important in diagnostic laboratories because it helps in confirming resistance of 
microorganism to an antimicrobial agent and it also monitors the activity of new 
antimicrobial agents. 
For bacterial and fungal MIC study, AQZR showed least MIC value i.e. 
125µg/ml against Staphylococcus aureus, E.coli, Pseudomonas auregenosa. The AQZR 
showed MIC value i.e. 250 µg/ml against Bacillus subtilis, Aspergillus niger, Monascus 
purpureus. 
 
Aqueous stem extract of Zanthoxylum rhetsa demonstrated wound healing 
properties comparable with that of antibiotic standard. Animals in the untreated group 
showed some degree of healing. As earlier suggested, healing in this untreated group 
may be due to self-immunity. It is important to note that throughout the period of wound 
treatment, the extracts did not cause irritation or pain to the animals as the rats neither 
show any signs of restlessness nor scratching/biting of wound site when the extract were 
applied. 
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In this investigation three models were used to assess the effect of the AQZR 
extracts as applied topically. The plant may have a beneficial influence on the various 
phases of wound healing like fibroplasias, collagen synthesis, and wound contraction, 
resulting in faster healing. The results of the present investigation showed that both plant 
extracts have definite wound healing action. 
 
Extract treated excision wounds showed an increased rate of wound contraction, 
leading to faster healing as confirmed by the increased healed area when compared to the 
control untreated group. The AQZR was recorded similar effectiveness when compared 
to the group treated with a commercial brand of 5% povidone iodine ointment in but the 
magnitude was lesser than standard. 
 
Increased wound contraction rate was also observed in the extract treated 
excision wounds, when compared to control. Povidone iodine ointment was used as a 
standard, the rate of healing was slightly more than the test AQZR. 
 
Measurement of the hydroxyproline could be used as an index for collagen 
turnover. Collagen is a major protein of the extracellular matrix and is the major 
component that ultimately contributes to wound strength. Breakdown of collagen 
liberates free hydroxyproline and its peptides. It was observed that Zanthoxylum rhetsa 
increased the collagen content of the skin ultimately and contributed to wound strength. 
Previous studies stated that there is a strong correlation between the collagen fiber 
formation and acceleration of wound healing. 
 
           From histopathological studies, it was observed that the phases of wound healing 
occurred in a timely manner. The untreated (control) wound healed slowly when 
compared to the wounds treated with AQZR.  Extract treated group shows large number 
of collagen tissue (fibrosis) and neovascularisation with minimal inflammatory cells. 
AQZR treated showed near to normal features, collagen tissue (fibrosis), and 
neovascularisation when compared to control group. 
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8. CONCLUSION 
  
Wound healing is a complex and continuous process that begins immediately 
after injury, followed by homeostasis, blood clotting, inflammation, proliferation and 
remodeling phases. All these phases can promote or prolong healing by influencing 
external or internal factors including infection sex hormones and nutrition. Delay in 
healing process increases the possibility of getting infected, improper recovery, and 
formation of unpleasant scar. 
 
The study thus demonstrated the wound healing activity of aqueous stem 
extract of Zanthoxylum rhetsa (Roxb) DC and found to be effective in the functional 
recovery of the wound. The extracts promote wound contraction; increases 
hydroxyproline, hexosamine and uronic acid of excision wound as compared to 
control group. The result may be attributed to the phytoconstituents such as 
flavonoids and phenolics present in it which may be due to their individual or 
cumulative effect that enhanced wound healing and provided scientific evidence to 
the ethnomedicinal futures of Zanthoxylum rhetsa(Roxb) DC. These findings could 
justify the inclusion of this plant in the management of wound healing. 
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